OpenAlex
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome
Work
Year: 2021
Type: article
Abstract: Significance Statement Rituximab is the standard therapy for childhood-onset complicated frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, most patients redevelop FRNS... more
Cites: 39
Cited by: 42
Related to: 10
FWCI: 6.43
Citation percentile (by year/subfield): 84.19
Subfield: Nephrology
Field: Medicine
Sustainable Development Goal Good health and well-being
Open Access status: bronze
Grant IDS JP15lk0201021, JP18k0201082